Allakos is throwing in the towel. After seeing phase 1 data in hives, the biotech has decided to drop the drug candidate and ...

Allakos (NASDAQ:ALLK) has dropped ~75% in premarket trading Monday after posting disappointing phase 1 results on AK006 for chronic spontaneous urticaria and deciding to end development. Due to ...

Allakos reports Phase 1 failure, lays off 75% of staff: The biotech said AK006 did not produce a clinical benefit in patients ...

U.S. President Donald Trump has directed federal agencies to assess China's performance under the Phase 1 trade deal that he ...

A live question and answer session will follow the formal presentations. A replay of the call will be available in the ...

The first phase of the plan, which calls for two officers to be present on each overnight train, kicked off Tuesday night. Officers are expected to ride the trains between 9 p.m. and 5 a.m. Some ...

U.S. President Donald Trump has directed federal agencies to assess China's performance under the Phase 1 trade deal that he ...